Table 2 Univariate analysis of factors associated with NIRS data improvements.
Univariate | |||
|---|---|---|---|
Odds ratio | 95% CI | p | |
Age > 70 y.o | 2.55 | 0.88–7.35 | 0.083 |
Female gender | 1.25 | 0.51–3.06 | 0.26 |
Etiology (%) | |||
HBV | 1.00 | 0.39–2.52 | 1.00 |
HCV | 2.23 | 0.72–6.92 | 1.00 |
Others | 1.43 | 0.38–5.44 | 0.60 |
Baseline BCAA | 1.15 | 0.46–2.86 | 0.77 |
l-Carnitine | 4.07 | 1.57–10.50 | 0.0038 |
Child–Pugh B or C | 1.62 | 0.55–4.79 | 0.38 |
Albumin ≤ 3.5 g/dL | 1.58 | 0.64–3.34 | 0.32 |
Total bilirubin > 0.9 mg/dL | 1.43 | 0.57–3.60 | 0.45 |
Ammonia > 50 μg/dL | 1.80 | 0.69–4.69 | 0.23 |
Platelet count < 100 × 103/μL | 1.42 | 0.57–3.52 | 0.45 |
Prothrombin time < 80% | 1.08 | 0.40–2.92 | 0.89 |
Total carnitine < 68 μmol/L | 1.63 | 0.53–5.04 | 0.40 |
Free carnitine > 52 μmol/L | 2.10 | 0.71–6.21 | 0.18 |
Acylcarnitine < 15.5 μmol/L | 1.59 | 0.53–4.80 | 0.41 |
NIRS data ≤ 0.07 mMmm | 6.53 | 2.26–19.01 | 0.0010 |
NCT-A < 42 s | 1.45 | 0.57–3.66 | 0.43 |
NCT-B < 98 s | 2.09 | 0.80–5.46 | 0.13 |
Skeletal muscle mass depletion | 0.65 | 0.19–2.1 | 0.48 |
